Verónica Llorens

3.1k total citations · 1 hit paper
11 papers, 2.4k citations indexed

About

Verónica Llorens is a scholar working on Neurology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Verónica Llorens has authored 11 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Surgery. Recurrent topics in Verónica Llorens's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers) and Genetic Neurodegenerative Diseases (4 papers). Verónica Llorens is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers) and Genetic Neurodegenerative Diseases (4 papers). Verónica Llorens collaborates with scholars based in Spain, United Kingdom and United States. Verónica Llorens's co-authors include Juan Carlos Gómez‐Esteban, Elena Lezcano, J.J. Zarranz, Olga Rodriguez, Janet Hoenicka, Teodoro del Ser, Javier Alegre‐Abarrategui, Begoña Atarés, Raquel Ros and Lídice Vidal and has published in prestigious journals such as Annals of Neurology, European Journal of Nuclear Medicine and Molecular Imaging and Journal of Neurology.

In The Last Decade

Verónica Llorens

11 papers receiving 2.4k citations

Hit Papers

The new mutation, E46K, of α‐synuclein causes parkinson a... 2003 2026 2010 2018 2003 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verónica Llorens Spain 9 2.1k 1.0k 791 439 420 11 2.4k
Israel Ampuero Spain 13 2.1k 1.0× 1.2k 1.2× 853 1.1× 423 1.0× 485 1.2× 19 2.6k
Elena Lezcano Spain 18 2.6k 1.3× 1.1k 1.1× 852 1.1× 493 1.1× 446 1.1× 23 2.9k
Begoña Atarés Spain 10 2.0k 1.0× 1.0k 1.0× 832 1.1× 500 1.1× 535 1.3× 12 2.4k
Jennifer A. Steiner United States 21 2.0k 0.9× 1.1k 1.1× 895 1.1× 746 1.7× 881 2.1× 34 3.0k
Mathias Toft Norway 31 2.1k 1.0× 871 0.9× 633 0.8× 778 1.8× 701 1.7× 82 2.7k
Wei‐Ping Gai Australia 25 1.2k 0.6× 828 0.8× 744 0.9× 366 0.8× 692 1.6× 35 2.3k
Ayako Takeda Japan 11 2.3k 1.1× 1.4k 1.3× 1.0k 1.3× 591 1.3× 581 1.4× 14 2.8k
Kiren Ubhi United States 26 1.0k 0.5× 806 0.8× 805 1.0× 590 1.3× 465 1.1× 36 2.0k
Dora Yearout United States 18 1.3k 0.6× 542 0.5× 443 0.6× 624 1.4× 487 1.2× 24 1.8k
Silke Nuber United States 23 1.3k 0.6× 884 0.9× 456 0.6× 316 0.7× 431 1.0× 37 1.8k

Countries citing papers authored by Verónica Llorens

Since Specialization
Citations

This map shows the geographic impact of Verónica Llorens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verónica Llorens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verónica Llorens more than expected).

Fields of papers citing papers by Verónica Llorens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verónica Llorens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verónica Llorens. The network helps show where Verónica Llorens may publish in the future.

Co-authorship network of co-authors of Verónica Llorens

This figure shows the co-authorship network connecting the top 25 collaborators of Verónica Llorens. A scholar is included among the top collaborators of Verónica Llorens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verónica Llorens. Verónica Llorens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Genollá, J, et al.. (2019). Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging. 46(7). 1567–1575. 16 indexed citations
2.
Gabilondo, Iñigo, Verónica Llorens, Manuel Castro‐Fernández, et al.. (2018). Myocardial MIBG scintigraphy in genetic Parkinson’s disease as a model for Lewy body disorders. European Journal of Nuclear Medicine and Molecular Imaging. 46(2). 376–384. 16 indexed citations
3.
Tijero, Beatriz, Iñigo Gabilondo, Elena Lezcano, et al.. (2015). Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations. Parkinsonism & Related Disorders. 21(7). 717–722. 16 indexed citations
4.
Tijero, Beatriz, Juan Carlos Gómez‐Esteban, Johanne Somme, et al.. (2013). Autonomic dysfunction in parkinsonian LRRK2 mutation carriers. Parkinsonism & Related Disorders. 19(10). 906–909. 24 indexed citations
5.
Berganzo, Koldo, Beatriz Tijero, Johanne Somme, et al.. (2013). Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related?. Journal of Neurology. 260(7). 1752–1756. 59 indexed citations
6.
Tijero, Beatriz, Juan Carlos Gómez‐Esteban, Elena Lezcano, et al.. (2012). Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene. Parkinsonism & Related Disorders. 19(1). 95–100. 32 indexed citations
7.
Berganzo, Koldo, Beatriz Tijero, Johanne Somme, et al.. (2011). SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy. Parkinsonism & Related Disorders. 18(1). 45–48. 26 indexed citations
8.
Gómez‐Esteban, Juan Carlos, et al.. (2011). Teratoma en un caso de encefalitis por anticuerpos contra el receptor de NMDA. Revista de Neurología. 53(9). 574–574. 1 indexed citations
9.
Zarranz, J.J., Javier Alegre‐Abarrategui, Juan Carlos Gómez‐Esteban, et al.. (2003). The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia. Annals of Neurology. 55(2). 164–173. 2133 indexed citations breakdown →
10.
Quintana, José M., et al.. (1997). Diaschisis and Neuropsychological Performance after Cerebellar Stroke. European Neurology. 37(2). 82–89. 57 indexed citations
11.
Fuente, Carmen de la, Verónica Llorens, Ignacio Banzo, & J.M. Carril. (1989). Gallium-67 citrate scintigraphy in Salmonella infected thrombus of a left ventricular aneurysm.. PubMed. 30(7). 1277–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026